Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

May 16, 2024

BUY
$31.71 - $38.95 $8,244 - $10,127
260 New
260 $10,000
Q4 2023

Feb 02, 2024

SELL
$31.71 - $38.95 $95 - $116
-3 Reduced 1.14%
260 $10,000
Q3 2023

Nov 13, 2023

SELL
$37.32 - $49.29 $213,918 - $282,530
-5,732 Reduced 95.61%
263 $10,000
Q2 2023

Jul 24, 2023

BUY
$39.98 - $47.68 $239,680 - $285,841
5,995 New
5,995 $273,000
Q4 2022

Jan 24, 2023

BUY
$49.7 - $57.71 $198 - $230
4 Added 1.56%
260 $13,000
Q3 2022

Nov 04, 2022

SELL
$53.86 - $66.8 $102,387 - $126,986
-1,901 Reduced 88.13%
256 $14,000
Q2 2022

Jul 22, 2022

SELL
$63.83 - $80.0 $95,745 - $120,000
-1,500 Reduced 41.02%
2,157 $139,000
Q1 2022

May 09, 2022

SELL
$76.85 - $89.45 $64,553 - $75,138
-840 Reduced 18.68%
3,657 $284,000
Q4 2021

Feb 15, 2022

BUY
$74.57 - $87.19 $3,579 - $4,185
48 Added 1.08%
4,497 $386,000
Q3 2021

Nov 12, 2021

BUY
$73.77 - $83.61 $41,384 - $46,905
561 Added 14.43%
4,449 $358,000
Q2 2021

Jul 23, 2021

BUY
$80.5 - $88.01 $2,415 - $2,640
30 Added 0.78%
3,888 $313,000
Q1 2021

May 10, 2021

SELL
$76.38 - $86.03 $419,249 - $472,218
-5,489 Reduced 58.72%
3,858 $325,000
Q4 2020

Feb 24, 2021

SELL
$75.39 - $82.36 $150 - $164
-2 Reduced 0.02%
9,347 $750,000
Q4 2020

Feb 12, 2021

BUY
$75.39 - $82.36 $335,862 - $366,913
4,455 Added 91.03%
9,349 $750,000
Q3 2020

Nov 10, 2020

BUY
$78.33 - $90.73 $66,893 - $77,483
854 Added 21.14%
4,894 $394,000
Q2 2020

Aug 12, 2020

BUY
$78.66 - $94.14 $179,423 - $214,733
2,281 Added 129.68%
4,040 $348,000
Q1 2020

May 13, 2020

BUY
$71.57 - $93.3 $125,891 - $164,114
1,759 New
1,759 $143,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.